Keywords: bayer, market, alza, new, viadur, implant, usa

Bayer to market Alza's new Viadur implant in the USA

Article | 06 April 2000

Print This

Bayer Corp has licensed commercial rights in the USA to Viadur(leuprolide acetate implant), a once-yearly implant for the palliative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in